The Japanese company will be investing an aggregate value of Rs 1,196 crore (US$ 184 million) to acquire an additional 14% stake in Reliance Capital Asset Management, in tranches, to reach a 49% stake.
“The boards of directors of both the companies - Nippon Life Insurance and Reliance Capital Asset Management - have approved the increase in stake by the Japanese partner, subject to regulatory approvals,” Reliance Capital said in a press release.
The transaction pegs Reliance Capital Asset Management’s valuation at Rs 8,542 crore (US$ 1.3 billion), the highest valuation till date for any asset management company in the country.
This transaction is expected to be completed within the current financial year, subject to receipt of regulatory approvals, it added.
At 11.10 am, the stock was up 4.6% at Rs 397 compared to 0.39% decline in S&P BSE Sensex. A combined 2.67 million shares changed hands on the counter on the BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)